| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/03/2011 | US20110053965 Sulfonated precursors of thymidine for the treatment of epithelial hyperplasias |
| 03/03/2011 | US20110053964 4-aminoquinazoline derivatives and methods of use thereof |
| 03/03/2011 | US20110053963 Tartrate salts of quinazoline based egfr inhibitors containing a zinc binding moiety |
| 03/03/2011 | US20110053962 Azaindole derivatives with a combination of partial nicotinic acetyl-choline receptor agonism and dopamine reuptake inhibition |
| 03/03/2011 | US20110053961 Substituted xanthine derivatives |
| 03/03/2011 | US20110053960 Method for treating pain syndrome and other disorders |
| 03/03/2011 | US20110053959 Pyrimidyl cyclopentanes as akt protein kinase inhibitors |
| 03/03/2011 | US20110053958 Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto |
| 03/03/2011 | US20110053957 Malonate salt of 4-((1r,3s)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and uses of same |
| 03/03/2011 | US20110053956 Treatment for Neurological and Mental Disorders |
| 03/03/2011 | US20110053955 Anti-cytokine heterocyclic compounds |
| 03/03/2011 | US20110053954 Method of treatment and/or prevention of brain, spinal or nerve injury |
| 03/03/2011 | US20110053953 AZA-Isoindolones and Their Use as Metabotropic Glutamate Receptor Potentiators - 613 |
| 03/03/2011 | US20110053952 2-heteroarylamino-pyrimidine derivatives as kinase inhibitors |
| 03/03/2011 | US20110053951 Methods for treating disorders using nmda nr2b-subtype selective antagonist |
| 03/03/2011 | US20110053950 4-benzylidene-3-methylpiperidine aryl carboxamide compounds useful as faah inhibitors |
| 03/03/2011 | US20110053949 4-[3-(aryloxy)benzylidene]-3-methyl piperidine aryl carboxamide compounds useful as faah inhibitors |
| 03/03/2011 | US20110053948 Pyrrolidines as nk3 receptor antagonists |
| 03/03/2011 | US20110053947 Arylchalcogenoarylalkyl-substituted imidazolidine-2,4-diones, process for preparation thereof, medicaments comprising these compounds and use thereof |
| 03/03/2011 | US20110053946 Aryl-Quinolyl Compounds and Their Use |
| 03/03/2011 | US20110053945 Salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihy-dro-5h-pyrrolo[3,4-b]pyrazine |
| 03/03/2011 | US20110053944 Substituted dihydropteridin-6-one derivatives, process for their preparation and their use as kinase inhibitors |
| 03/03/2011 | US20110053943 CARBAMATE AND UREA INHIBITORS OF 11ß-HYDROXYSTEROID DEHYDROGENASE 1 |
| 03/03/2011 | US20110053942 Orally disintegrating tablets |
| 03/03/2011 | US20110053941 IDO Inhibitors |
| 03/03/2011 | US20110053940 3,4-substituted piperidine derivatives as renin inhibitors |
| 03/03/2011 | US20110053939 Novel aromatic nitro compounds |
| 03/03/2011 | US20110053938 Compounds and Compositions For Treating Cancer |
| 03/03/2011 | US20110053937 Inhibitors of the Interaction Between MDM2 and P53 |
| 03/03/2011 | US20110053936 substituted spiro[cycloalkyl-1,3'-indol]-2'(1'h)-one derivatives and their use as p38 mitogen-activated kinase inhibitors |
| 03/03/2011 | US20110053935 Fused pyridines active as inhibitors of c-met |
| 03/03/2011 | US20110053934 Compounds and methods of treatment |
| 03/03/2011 | US20110053933 Hydroxyquinoxalinecarboxamide derivative |
| 03/03/2011 | US20110053932 Protein Kinase Inhibitors and Methods for Using Thereof |
| 03/03/2011 | US20110053931 Quinoline compounds and methods of use |
| 03/03/2011 | US20110053930 Inhibitors of the bmp signaling pathway |
| 03/03/2011 | US20110053929 Imidazo-, pyrazolopyrazines and imidazotriazines and their use |
| 03/03/2011 | US20110053928 Pyrimidothienoindazoles |
| 03/03/2011 | US20110053927 Nanoparticle formation via rapid precipitation |
| 03/03/2011 | US20110053926 New Pharmaceutically-Active Compounds for the Treatment of Respiratory Diseases |
| 03/03/2011 | US20110053925 Hydroxamate-Based Inhibitors of Deacetylases |
| 03/03/2011 | US20110053924 Substituted piperidines as renin inhibitors |
| 03/03/2011 | US20110053923 Chemical compounds 610 |
| 03/03/2011 | US20110053922 Spiro (Piperidine-4,2'-Pyrrolidine)-1-(3,5-Trifluoromethyl Phenyl) Methylcarboxamides As NK1 Tachikynin Receptor Antagonists |
| 03/03/2011 | US20110053921 Hexahydrooxazinopterine compounds |
| 03/03/2011 | US20110053920 Substituted bicyclic pyrimidines |
| 03/03/2011 | US20110053918 Gamma secretase modulators |
| 03/03/2011 | US20110053917 Allosteric Modulators of the A1 Adenosine Receptor |
| 03/03/2011 | US20110053916 Pyrimidine compounds as tuberculosis inhibitors |
| 03/03/2011 | US20110053915 HETEROCYCLIC INHIBITORS OF AN Hh-SIGNAL CASCADE, MEDICINAL COMPOSITIONS BASED THEREON AND METHODS FOR TREATING DISEASES CAUSED BY THE ABERRANT ACTIVITY OF AN Hh-SIGNAL SYSTEM |
| 03/03/2011 | US20110053914 Pharmaceutical Combination Comprising 6-Dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol or 6-Dimethylaminomethyl-1-(3-hydroxy-phenyl)-cyclohexane-1,3-diol and an Antiepileptic |
| 03/03/2011 | US20110053913 Methods and Therapies for Alleviating Pain |
| 03/03/2011 | US20110053912 Pyrimidine compound |
| 03/03/2011 | US20110053911 Tricyclic derivatives as inhibitors of poly(adp-ribose) polymerase (parp) |
| 03/03/2011 | US20110053910 2 -heterocyclyloxybenzoyl amino heterocyclyl compounds as modulators of glucokinase for the treatment of type 2 diabetes |
| 03/03/2011 | US20110053909 Compounds - 801 |
| 03/03/2011 | US20110053908 Azetidine-derived compounds, preparation method therefor and therapeutic use of same |
| 03/03/2011 | US20110053907 Substituted pyrimidines and triazines and their use in cancer therapy |
| 03/03/2011 | US20110053906 Protein kinase inhibitors and use thereof |
| 03/03/2011 | US20110053905 Compounds as tyrosine kinase modulators |
| 03/03/2011 | US20110053904 Carbocyclic glyt1 receptor antagonists |
| 03/03/2011 | US20110053903 Pharmaceutical compositions based on azetidine derivatives |
| 03/03/2011 | US20110053902 Amino derivatives of androstanes and androstenes as medicaments for cardiovascular disorders |
| 03/03/2011 | US20110053901 Acetyl mimic compounds for the inhibition of isoprenyl-s-cysteinyl methyltransferase |
| 03/03/2011 | US20110053900 Progesterone antagonists such as cdb-4124 in the treatment of breast cancer |
| 03/03/2011 | US20110053899 Use of lanostane and poria extract in treating diabetes |
| 03/03/2011 | US20110053898 Topical composition comprising vitamin d analogue and corticosteroids |
| 03/03/2011 | US20110053897 Compounds and compositions as syk kinase inhibitors |
| 03/03/2011 | US20110053896 Osmolytes for the treatment of allergic or viral respiratory diseases |
| 03/03/2011 | US20110053895 Use of mitochondrially-addressed compounds for preventing and treating cardiovascular diseases |
| 03/03/2011 | US20110053894 Broad Spectrum Antiviral and Methods of Use |
| 03/03/2011 | US20110053893 Compounds and compositions as tlr activity modulators |
| 03/03/2011 | US20110053892 Imidazo[4,5-d]Pyridazine Compounds For Treating Viral Infections |
| 03/03/2011 | US20110053890 Synthetic analogs of bacterial quorum sensors |
| 03/03/2011 | US20110053889 Prenatal and postnatal screening and treatment of critical monosaccharide deficiencies for neurologic and immunologic function |
| 03/03/2011 | US20110053888 Mixture Of Carboyhydrates And Its Use In The Preparation Of A Product Intended For Oral Or Enteral Nutrition |
| 03/03/2011 | US20110053887 Socs3 expression promoter, drug and food containing the same and method of promoting the expression of socs3 |
| 03/03/2011 | US20110053886 Delayed Self-Gelling Alginate Systems and Uses Thereof |
| 03/03/2011 | US20110053885 Pharmaceutical agent having long-lasting effect of treating arthritic disorders |
| 03/03/2011 | US20110053884 Potent combinations of zidovudine and drugs that select for the k65r mutation in the hiv polymerase |
| 03/03/2011 | US20110053882 Methods and compounds for preventing and treating a tumour |
| 03/03/2011 | US20110053881 6-Disubstituted Or Unsaturated Bicyclic Nucleic Acid Analogs |
| 03/03/2011 | US20110053880 Composition for treatment of tuberculosis |
| 03/03/2011 | US20110053879 Picoplatin and amrubicin to treat lung cancer |
| 03/03/2011 | US20110053878 Acid-sensitive linkers for drug delivery |
| 03/03/2011 | US20110053877 Nimesulide and muscle relaxant combinations thereof |
| 03/03/2011 | US20110053876 macrolides and their use |
| 03/03/2011 | US20110053875 Macrolide synthesis process and solid-state forms |
| 03/03/2011 | US20110053874 Use of flavonoide compounds for the prophylaxis and therapy of ischaemic or inflammatory heart and cardiovascular diseases |
| 03/03/2011 | US20110053873 Hsp90 inhibitors |
| 03/03/2011 | US20110053872 Pharmaceutical Composition For Preventing And Treating Diabetic Nephropathy And The Preparation Method Thereof |
| 03/03/2011 | US20110053871 Methods of regulating actin cytoskeletal rearrangement and intercellular gap formation |
| 03/03/2011 | US20110053870 Use of isothiocyanate derivatives as anti-myeloma agents |
| 03/03/2011 | US20110053869 Methods and compositions for inhibiting progression to chronic cardiac failure |
| 03/03/2011 | US20110053868 L-sugar colon cleansing agent and uses thereof |
| 03/03/2011 | US20110053867 L-sugar colon cleansing agent and uses thereof |
| 03/03/2011 | US20110053866 Pharmaceutical compositions |
| 03/03/2011 | US20110053862 Compositions comprising survivin sirna and methods of use thereof |
| 03/03/2011 | US20110053861 Compositions comprising nuclear factor-kappa b (nf-kb) sirna and methods of use |
| 03/03/2011 | US20110053860 COX-2 function and wound healing |